While cancer pathways contained prostate cancer, thyroid cancer, chronic myeloid leukemia, melanoma, glioma, ErbB signaling pathway, and mTOR signaling pathway. This evidence concerns the gene MTOR and chronic myelogenous leukemia, BCR-ABL1 positive.